- Home
- CLRB vs FLGC Comparison
CLRB vs FLGC Comparison
Compare CLRB & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- FLGC
- Stock Information
- Founded
- CLRB 2002
- FLGC 2019
- Country
- CLRB United States
- FLGC United States
- Employees
- CLRB N/A
- FLGC 76
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- CLRB Health Care
- FLGC Health Care
- Exchange
- CLRB Nasdaq
- FLGC Nasdaq
- Market Cap
- CLRB 12.5M
- FLGC 11.7M
- IPO Year
- CLRB N/A
- FLGC 2021
- Fundamental
- Price
- CLRB $0.25
- FLGC $0.68
- Analyst Decision
- CLRB Hold
- FLGC Strong Buy
- Analyst Count
- CLRB 2
- FLGC 3
- Target Price
- CLRB N/A
- FLGC $5.00
- AVG Volume (30 Days)
- CLRB 729.7K
- FLGC 286.8K
- Earning Date
- CLRB 05-13-2025
- FLGC 05-13-2025
- Dividend Yield
- CLRB N/A
- FLGC N/A
- EPS Growth
- CLRB N/A
- FLGC N/A
- EPS
- CLRB N/A
- FLGC N/A
- Revenue
- CLRB N/A
- FLGC $53,260,000.00
- Revenue This Year
- CLRB N/A
- FLGC $2.33
- Revenue Next Year
- CLRB N/A
- FLGC N/A
- P/E Ratio
- CLRB N/A
- FLGC N/A
- Revenue Growth
- CLRB N/A
- FLGC N/A
- 52 Week Low
- CLRB $0.22
- FLGC $0.42
- 52 Week High
- CLRB $3.49
- FLGC $2.11
- Technical
- Relative Strength Index (RSI)
- CLRB 39.17
- FLGC 61.10
- Support Level
- CLRB $0.23
- FLGC $0.68
- Resistance Level
- CLRB $0.27
- FLGC $0.75
- Average True Range (ATR)
- CLRB 0.02
- FLGC 0.07
- MACD
- CLRB -0.00
- FLGC 0.02
- Stochastic Oscillator
- CLRB 15.12
- FLGC 82.02
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.